The Danish TURNER Cryopreservation Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to investigate if cryopreservation of ovarian tissue in girls with Turner syndrome can improve their fertility and lead to increased number of liveborn babies of Turner syndrome mothers. Women with Turner syndrome suffer from premature ovarian insufficiency which leads to infertility and lack of estrogen. The main questions it aims to answer are: * Does the number of pregnancies and liveborn children increase after cryopreservation of ovarian tissue in turner syndrome? * Is the possible to predict when a girl with Turner syndrome reach menopause using monitoring of sex hormones? * Is it possible to identify any genes causing ovarian failure in Turner syndrome females? Participants between 2-18 years old will be asked to participate in a laparoscopic surgery and removal of one ovary in order to cryopreserve the tissue until adulthood. The the cortical tissue will be autotransplanted in order to preserve fertility. The participant will during the study period be monitored using sex hormones. Furthermore, the investigators wish to investigate the ovarian tissue using RNA sequencing and DNA methylation analysis. No comparison group is present.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 2
Maximum Age: 17
Healthy Volunteers: t
View:

• 45,X karyotype or other Turner variant karyotypes (45,X/46,XX mosaicism, ring X mosaicism, isochromosome X)

• Age 2-17 years old

• Ability to participate in a physical examination including a cardiac examination.

• Signed consent from both parents.

Locations
Other Locations
Denmark
Mette Viuff
RECRUITING
Aarhus
Contact Information
Primary
Mette H Viuff, MD PhD
metteviuff@clin.au.dk
+45 23705085
Time Frame
Start Date: 2023-01-01
Estimated Completion Date: 2051-01-01
Participants
Target number of participants: 100
Sponsors
Leads: University of Aarhus

This content was sourced from clinicaltrials.gov